Page 138 - 《中国药房》2024年14期
P. 138
mTORC1-线粒体能量代谢治疗血瘀证慢性肾衰竭大鼠 dation to reveal the pharmacological mechanism of narin‐
的机制研究[J]. 中国中药杂志,2024,49(7):1888-1895. gin against renal fibrosis[J]. Open Med(Wars),2023,18
LIU X Y,HUANG Z M,QIU S B,et al. Mechanism of (1):20230736.
Notoginseng radix et rhizoma in regulating PI3K/Akt/ [31] LI X Y,HUANG X,FENG Y M,et al. Cylindrin from Im‐
mTORC1-mitochondrial energy metabolism to treat perata cylindrica inhibits M2 macrophage formation and
chronic renal failure in rats with blood stasis syndrome[J]. attenuates renal fibrosis by downregulating the LXR-α/
China J Chin Mater Med,2024,49(7):1888-1895. PI3K/Akt pathway[J]. Eur J Pharmacol,2023,950:
[21] LIU Y,WANG J Y. Ferroptosis,a rising force against re‐ 175771.
nal fibrosis[J]. Oxid Med Cell Longev,2022,2022: [32] WANG W D,SHENG L,CHEN Y Y,et al. Total couma‐
7686956. rin derivates from Hydrangea paniculata attenuate renal
[22] 邱莎,杨丽,谭睿陟,等. 黄柏酮对单侧输尿管梗阻模型 injuries in cationized-BSA induced membranous ne‐
小鼠肾间质纤维化及铁死亡的影响[J]. 中国药房,2023, phropathy by inhibiting complement activation and inter‐
34(5):554-559. leukin 10-mediated interstitial fibrosis[J]. Phytomedicine,
QIU S,YANG L,TAN R Z,et al. Effects of obacunone on 2022,96:153886.
renal interstitial fibrosis and ferroptosis in unilateral ure‐ [33] LI R,SHI C R,WEI C T,et al. Fufang Shenhua tablet in‐
teral obstruction model mice[J]. China Pharm,2023,34 hibits renal fibrosis by inhibiting PI3K/Akt[J]. Phytomedi‐
(5):554-559. cine,2023,116:154873.
[23] HAO J L,ZHANG W Q,HUANG Z Q. Bupivacaine [34] YUAN H,WU X L,WANG X M,et al. Chinese herbal de‐
modulates the apoptosis and ferroptosis in bladder cancer coction astragalus and angelica exerts its therapeutic ef‐
via phosphatidylinositol 3-kinase(PI3K)/Akt pathway[J]. fect on renal interstitial fibrosis through the inhibition of
Bioengineered,2022,13(3):6794-6806. MAPK,PI3K-Akt and TNF signaling pathways[J]. Genes
[24] LI X,ZOU Y,XING J,et al. Pretreatment with roxadustat Dis,2022,9(2):510-521.
(FG-4592)attenuates folic acid-induced kidney injury [35] LUO H Y,WANG M N,XU K,et al. Effect of Fushen‐
through antiferroptosis via Akt/GSK-3β/Nrf2 pathway[J]. gong decoction on PTEN/PI3K/Akt/NF-κB pathway in
Oxid Med Cell Longev,2020,2020:6286984. rats with chronic renal failure via dual-dimension network
[25] WANG Z H,CHEN Z,LI B S,et al. Curcumin attenuates pharmacology strategy[J]. Front Pharmacol,2022,13:
renal interstitial fibrosis of obstructive nephropathy by 807651.
suppressing epithelial-mesenchymal transition through in‐ [36] WANG Z,JIAN G H,CHEN T,et al. The Qi-Bang-Yi-
hibition of the TLR4/NF-κB and PI3K/Akt signalling Shen formula ameliorates renal dysfunction and fibrosis in
pathways[J]. Pharm Biol,2020,58(1):828-837. rats with diabetic kidney disease via regulating PI3K/Akt,
[26] GU H P,LI J R,NI Y H. Sinomenine improves renal fibro‐ ERK and PPARγ signaling pathways[J]. Eur J Histochem,
sis by regulating mesenchymal stem cell-derived exo‐ 2023,67(1):3648.
somes and affecting autophagy levels[J]. Environ Toxicol, [37] FAN Z L,CHEN J J,YANG Q R,et al. Network pharma‐
2023,38(10):2524-2537. cology and experimental validation to reveal the pharma‐
[27] DOU F,LIU Y T,LIU L M,et al. Aloe-emodin amelio‐ cological mechanisms of chongcaoyishen decoction
rates renal fibrosis via inhibiting PI3K/Akt/mTOR signa- against chronic kidney disease[J]. Front Mol Biosci,2022,
ling pathway in vivo and in vitro[J]. Rejuvenation Res, 9:847812.
2019,22(3):218-229. [38] 李荣荣,马华,田树杰,等. 芪红通瘀饮对肾间质纤维化
[28] SONG Y Y,LIU W,TANG K,et al. Mangiferin alleviates 大鼠肾组织Wnt/β-catenin信号通路的影响[J]. 中华中医
renal interstitial fibrosis in streptozotocin-induced diabetic 药杂志,2020,35(4):1755-1759.
mice through regulating the PTEN/PI3K/Akt signaling LI R R,MA H,TIAN S J,et al. Effects of Qihong tongyu
pathway[J]. J Diabetes Res,2020,2020:9481720. decoction on Wnt/β-catenin signaling pathway in renal tis‐
[29] TU H T,MA D H,LUO Y Y,et al. Quercetin alleviates sue of rats with renal interstitial fibrosis[J]. China J Tradit
chronic renal failure by targeting the PI3K/Akt pathway Chin Med Pharm,2020,35(4):1755-1759.
[J]. Bioengineered,2021,12(1):6538-6558. (收稿日期:2024-01-20 修回日期:2024-06-18)
[30] ZHONG Y N,LI X,XIE J,et al. Network pharmacology (编辑:邹丽娟)
combined with molecular docking and experimental vali‐
· 1800 · China Pharmacy 2024 Vol. 35 No. 14 中国药房 2024年第35卷第14期